Original Article

Clinical Study of Long-Term Survival in Colorectal Cancer Patients in Thailand: A 10-Year Follow-Up

Abstract

Background: In Thailand, data on colorectal cancer (CRC) patient characteristics and overall survival (OS) rates are limited. We aimed to describe the overall 5-year, 10-year survival and to examine factors effecting the survival outcome among patients who were diagnoses of colorectal cancer.

Methods: We reviewed medical records of patients diagnosed with invasive CRC from 2007 through 2016. Demographic and clinical data were collected upon diagnosis. Kaplan-Meier method and Cox proportional hazards model to evaluate the association of overall (OS) with risk factors.

Results: A total of 3,402 CRC patients (colon 59.4%, rectum 34. 5%, and rectosigmoid 6.1%) were identified. Mean (SD) and median age were 62.9 (12.7) and 63 years old (rang 14-98 years). Stages at diagnosis were I (10.1%), II (23.3), III (35.9%) and IV (30.7%). Five-year and 10-year OS of the entire cohort were 52.7% and 41.5%, respectively. Over the part 10 years, there was a trend toward improved 5-year OS in stages I, II and III. However, 3-year OS in stage IV patients remained unchanged. Confirmed poor prognostic factors included patient age ≥65 years, high grade, and advanced stage at diagnosis.

Conclusion: Advanced disease was a significant prognostic factor for shorter survival. A trend toward improvement in 5-year OS in early stages over the past decade might be related to better surgical quality, improved radiation technique, and adjuvant chemotherapy. Given that patients received better systemic treatment in stage IV disease, the reason their OS was not improved should be examined.

 

1. Moghimi-Dehkordi B, Safaee A (2012). An overview of colorectal cancer survival rates and prognosis in Asia. World J Gas-trointeat Oncol, 4(4):71-75.
2. Bray F, Ferlay J, Soerjomataram I, et al (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin,68(6):394-424.
3. Arnold M, Sierra MS, Laversanne M, et al (2017). Global patterns and trends in colorectal cancer incidence and mortality. Gut, 66(4):683-691.
4. Rawla P, Sunkara T, Barsouk A (2019). Epi-demiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol, 14(2):89-103.
5. Imsamran W, Pattatang A, Supaattagron P,et al(2018). Cancer in Thailand Volume IX:2013-2015. [cited 2020 December 15] Available from: www.nci.go.th/th/File_download/Nci%20Cancer%20in%20Thailand%20IX%20OK.pdf
6. Hong S, Won YJ, Park YR, et al (2020). Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017. Cancer Res Treat, 52(2):335-350.
7. Kittrongsiri K, Wanitsuwan W, Pre-chawittayakul P, et al (2020). Survival anal-ysis of colorectal cancer patients in a Thai hospital-based cancer registry. Expert Rev Gastroenterol Hepatol: 14(4):291-300.
8. Fritz A, Percy C, Jack A, et al. International Classification of Diseases for Oncology: Third Edition. [cited 2020 December 20] Available from: http://www.who.int/standards/classifications/other- classifications/international-classification-of-diseases-for-oncology.
9. Tamakoshi A, Nakamura K, Ukawa S, et al (2017). Characteristics and prognosis of Japanese colorectal cancer patients: The Biobank Japan Project. J Epidemiol, 27(3):36-42.
10. Chiang CJ, Lo WC, Yang YW, et al (2016). Incidence and survival of adult cancer pa-tients in Taiwan, 2002-2012. J Formos Med Assoc, 115(12):1076-1088.
11. White A, Joseph D, Rim SH, et al (2017). Colon cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study. Cancer, 123(Supl 24):5014-5036.
12. Brenner H, Bouvier AM, Foschi R, et al (2012). Progress in colorectal cancer sur-vival in Europe from the late 1980s to the early 21st century: The EUROCARE study. Int J Cancer, 131(7):1649-58.
13. Stor Z, Blagus R, Tropea A, Biondi A (2019). Net survival of patients with colo-rectal cancer: a comparison of two peri-ods. Updates Surg, 71(4): 687-694.
14. AGuero F, Murta-Nascimento C, Gallen M, et al (2012). Colorectal cancer survival: Result from a hospital-based cancer reg-istry. Rev esp Enferm Dig, 104(11):572-577
15. Lee CH, Cheng SC, Tung HY, et al (2018). The Risk Factors Affecting Survival in Colorectal Cancer in Taiwan. Iran J Public Health, 47(4):519-530.
16. Hippisley-Cox J, Coupland C (2017). Devel-opment and validation of risk prediction equations to estimate survival in patients with colorectal cancer: cohort study. BMJ, 357:j2497.
17. Chiu HM, Hsu WF, Chang LC, Wu MH (2017). Colorectal Cancer Screening in Asia. Curr Gastroenterol Rep, 19(10):47.
18. Doubeni CA (2014). The impact of colorec-tal cancer screening on the US popula-tion: Is it time to celebrate?: CRC Screen-ing and Incidence. Cancer,120(8):2810-2813.
19. Zavoral M, Suchanek S, Zavad F, et al (2009). Colorectal cancer screening in Eu-rope. World J Gastroenterol, 15(47):5907-5915.
20. Wang YW, Chen HH, Wu MS, Chiu HM (2018). Current status and future chal-lenge of population-based organized col-orectal cancer screening: Lesson from the first decade of Taiwanese program. J Formos Med Assoc, 117(5):358-364.
21. Phimha S, Promthet S, Suwanrungruang K, et al (2019). Health Insurance and Colo-rectal Cancer Survival in Khon Kaen, Thailand. Asian Pac J Cancer Prev, 20(6):1797-1802.
22. Phiphatpatthamaamphan K, Vilaichone RK (2016). Colorectal Cancer in the Central Region of Thailand. Asian Pac J Cancer Prev, 17(7):3647-3650.
23. Chindaprasirt J, Sookprasert A, Wirasorn K, et al (2012). Cost of Colorectal Cancer Care in Hospitalized Patients of Thailand. J Med Assoc Thai, 98(7):196.
24. Tangcharoensathien V, Patcharanarumol W, Suwanwela W, et al (2020). Defining the Benefit Package of Thailand Universal Coverage Scheme: From Pragmatism to Sophistication. Int J Health Policy Manag,9(4),133-137.
25. Meguid RA, Slidell MB, Wolfgang CL, et al (2008). Is There a Difference in Survival Between Right-Versus Left-Sided Colon Cancers? Ann Surg Oncol, 15(9):2388-2394.
26. Yahagi M, Okabayashi K, Hasegawa H, et al (2016). The Worse Prognosis of Right-Sided Compared with Left-Silded Colon Cnacers: a Systematic Review and Mete-analysis. J Gastrointest Surg, 20(3):648-655.
27. Nitsche U, Stogbauer F, Spath C, et al (2016). Right-Sided Colon Cancer as a Distinct Histopathological Subtype with Reduced Prognosis. Dig Surg, 33(2):157-163.
28. Warschkow R, Sulz MC, Marti L, et al (2016). Better survival in right-sided ver-sus left-sided stage I-III colon cancer pa-tients. BMC Cancer, 16:554.
29. Narayanan S, Gabriel E, Attwood K, et al (2018). Association of Clinicopathologic and Molecular Markers on Stage-specific Survival of Right Versus Left Colon Can-cer. Clin Colorectal Cancer, 17(4):e671-e678.
Files
IssueVol 51 No 11 (2022) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/ijph.v51i11.11171
Keywords
Colorectal Cancer Right-sided Left-sided Survival Thailand
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Thokanit N, Promchana S, Thonkamdee T, Jitkasikorn P, Siripoon T, Ngamphaiboon N, Sirachainan E. Clinical Study of Long-Term Survival in Colorectal Cancer Patients in Thailand: A 10-Year Follow-Up. Iran J Public Health. 2022;51(11):2538-2548.